Federal Register / Vol. 65, No. 128 / Monday, July 3, 2000 / Notices 41079

Panel: Community-Based Strategies to

Increase HIV Testing of Persons at High Risk

in Communities of Color, PA# 00100.

Times and Dates: 9 a.m.–12 p.m., August

22, 2000 (Open), 12 p.m.–4:30 p.m., August

22, 2000 (Closed), 8:30 a.m.–4:30 p.m.,

August 23, 2000 (Closed), 8:30 a.m.–4:30

p.m., August 24, 2000 (Closed), 8:30 a.m.–

4:30 p.m., August 25, 2000 (Closed).

Place: Crowne Plaza Airport Hotel, 1325

Virginia Avenue, Atlanta, GA 30344.

Telephone 404/768–6660.

Status: Portions of the meeting will be

closed to the public in accordance with

provisions set forth in section 552b(c)(4) and

(6), Title 5 U.S.C., and the Determination of

the Associate Director for Management and

Operations, CDC, pursuant to Public Law 92–

463.

Matters to be Discussed: The meeting will

include the review, discussion, and

evaluation of applications received in

response to Program Announcement 00100.

Contact Person For More Information: Beth

Wolfe, Prevention Support Office, National

Center for HIV, STD, and TB Prevention,

CDC, Corporate Square Office Park, 11

Corporate Square Boulevard, M/S E07,

Atlanta, Georgia 30329, telephone 404/639–

8025, e-mail eow1@cdc.gov.

The Director, Management Analysis and

Services Office, has been delegated the

authority to sign Federal Register Notices

pertaining to announcements of meetings and

other committee management activities, for

the both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: June 23, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 00–16721 Filed 6–30–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Disease, Disability and Injury

Prevention and Control Special

Emphasis Panel: Optimizing Strategies

to Provide Sexually Transmitted

Disease (STD) Partner Services, PA#

00080.

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following meeting.

Name: Disease, Disability and Injury

Prevention and Control Special Emphasis

Panel: Optimizing Strategies to Provide

Sexually Transmitted Disease (STD) Partner

Services, PA# 00080.

Times and Dates: 8:30 a.m–9 a.m., August

29, 2000 (Open), 9 a.m.–4:30 p.m., August 29,

2000 (Closed), 8:30 a.m.–4:30 p.m., August

30, 2000 (Closed).

Place: Centers for Disease Control and

Prevention, 12 Corporate Square Boulevard,

Building 12, Conference Rooms 1203 and

1307, Atlanta, GA 30329.

Status: Portions of the meeting will be

closed to the public in accordance with

provisions set forth in section 552b(c)(4) and

(6), Title 5 U.S.C., and the Determination of

the Associate Director for Management and

Operations, CDC, pursuant to Public Law 92–

463.

Matters to be Discussed: The meeting will

include the review, discussion, and

evaluation of applications received in

response to Program Announcement 00080.

Contact Person for more Information: Beth

Wolfe, Prevention Support Office, National

Center for HIV, STD, and TB Prevention,

CDC, Corporate Square Office Park, 11

Corporate Square Boulevard, M/S E07,

Atlanta, Georgia 30329, telephone 404/639–

8025, e-mail eow1@cdc.gov.

The Director, Management Analysis and

Services Office, has been delegated the

authority to sign Federal Register Notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: June 23, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 00–16722 Filed 6–30–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Statement of Organization, Functions,

and Delegations of Authority

Part C (Centers for Disease Control

and Prevention) of the Statement of

Organization, Functions, and

Delegations of Authority of the

Department of Health and Human

Services (45 FR 67772–76, dated

October 14, 1980, and corrected at 45 FR

69296, October 20, 1980, as amended

most recently at 65 FR 30125–26, dated

May 10, 2000) is amended to retitle the

Office of Data Processing and Services

(ODPS), National Center for Health

Statistics (NCHS), to the Office of

Information Technology and Services,

and revise the functional statement.

Section C–B, Organization and

Functions, is hereby amended as

follows:

Delete the title and functional

statement for the Office of Data

Processing and Services (CS3) and insert

the following:

Office of Information Technology and

Services (CS3). (1) Participates in the

development of policy, long-range plans

and programs of the Center; (2) Directs,

plans and coordinates the Information

Services and Information Technology

Infrastructure of the Center; (3) Provides

IRM policy coordination for the Center

and IRM procurement approval

authority for software, hardware and

systems contract support; (4) Provides

liaison with other public and private

health agencies, foundations and

statistical agencies on Information

Technology and electronic data

dissemination activities; and (5) Serves

as the focal point for advanced

Information Technology infrastructure

research activities for NCHS-wide

systems and in that capacity represents

NCHS in developing technology

partnerships with other agencies both

public and private.

Dated: June 18, 2000.

Jeffrey P. Koplan,

Director.

[FR Doc. 00–16791 Filed 6–30–00; 8:45 am]

BILLING CODE 4160–18–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 00F–1366]

Nippon Shokubai; Filing of Food

Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Nippon Shokubai has filed a

petition proposing that the food additive

regulations be amended to provide for

the safe use of methylmethacrylatetrimethylolpropane trimethacrylate

copolymer as an antiblocking agent in

linear low-density polyethylene

intended for use in contact with food.

FOR FURTHER INFORMATION CONTACT:

Julius Smith, Center for Food Safety and

Applied Nutrition (HFS–215), Food and

Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–418–3091.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 409(b)(5) (21 U.S.C. 348(b)(5))),

notice is given that a food additive

petition (FAP 0B4713) has been filed by

Nippon Shokubai, c/o Keller &

Heckman, 1001 G St., NW., suite 500

West, Washington, DC 20001. The

petition proposes to amend the food

additive regulations in § 177.1520

Olefins polymers (21 CFR 177.1520) to

provide for the safe use of